Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy

Management of thyroid eye disease: a Consensus Statement by the

Teprotumumab: Interpreting the Clinical Trials in the Context of

Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO

Management of thyroid eye disease: a Consensus Statement by the

Proposal for Standardization of Primary and Secondary Outcomes in

Graves Disease: Practice Essentials, Pathophysiology, Epidemiology

PDF) Management of Thyroid Eye Disease: A Consensus Statement by

Biomedicines, Free Full-Text

Biomedicines, Free Full-Text